NO994640L - Hostestillende midler - Google Patents

Hostestillende midler

Info

Publication number
NO994640L
NO994640L NO994640A NO994640A NO994640L NO 994640 L NO994640 L NO 994640L NO 994640 A NO994640 A NO 994640A NO 994640 A NO994640 A NO 994640A NO 994640 L NO994640 L NO 994640L
Authority
NO
Norway
Prior art keywords
theobromine
additives
salts
solid
active ingredients
Prior art date
Application number
NO994640A
Other languages
English (en)
Other versions
NO994640D0 (no
Inventor
Dezs Korbonits
Peter Arsnyi
Istvsn Jelinek
Endre Mikus
Original Assignee
Dezs Korbonits
Peter Arsnyi
Istvsn Jelinek
Endre Mikus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dezs Korbonits, Peter Arsnyi, Istvsn Jelinek, Endre Mikus filed Critical Dezs Korbonits
Publication of NO994640L publication Critical patent/NO994640L/no
Publication of NO994640D0 publication Critical patent/NO994640D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Anvendelse av teobromin og/eller dens salter og/eller dens komplekser eventuelt i blanding med andre kjente aktive ingredienser og inerte, faste eller flytende bærere, additiver og hjelpestoffer for fremstilling av et farmasøytisk preparat egnet for å lindre hostesyndrom. Ytterligere formål med oppfinnelsen er en fremgangsmåte for behandling av menneske eller dyr som er i en tilstand der lindring av hoste er ønskelig som omfatter trinnet for administrering av en effektiv mengde teobromin og/eller dens salter og/eller dens komplekser i form av en blanding med andre kjente aktive ingredienser og egnede inerte, faste eller flytende bærere, additiver og hjelpestoffer.
NO994640A 1997-03-26 1999-09-24 Hostestillende midler NO994640D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700654A HUP9700654A2 (hu) 1997-03-26 1997-03-26 Teobromin tartalmú köhögéscsillapító készítmények
PCT/HU1998/000027 WO1998042322A2 (en) 1997-03-26 1998-03-20 Antitussive compositions

Publications (2)

Publication Number Publication Date
NO994640L true NO994640L (no) 1999-09-24
NO994640D0 NO994640D0 (no) 1999-09-24

Family

ID=89994918

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994640A NO994640D0 (no) 1997-03-26 1999-09-24 Hostestillende midler

Country Status (23)

Country Link
US (1) US6348470B1 (no)
EP (1) EP0969843B1 (no)
JP (1) JP4450872B2 (no)
KR (1) KR100420370B1 (no)
CN (1) CN1251039A (no)
AT (1) ATE218868T1 (no)
AU (1) AU6741498A (no)
BG (1) BG103780A (no)
BR (1) BR9809057A (no)
CA (1) CA2284774C (no)
CZ (1) CZ295801B6 (no)
DE (1) DE69805983T2 (no)
DK (1) DK0969843T3 (no)
EA (1) EA001971B1 (no)
EE (1) EE9900428A (no)
ES (1) ES2178188T3 (no)
HU (1) HUP9700654A2 (no)
IL (2) IL131811A0 (no)
NO (1) NO994640D0 (no)
PL (1) PL190899B1 (no)
PT (1) PT969843E (no)
SK (1) SK285023B6 (no)
WO (1) WO1998042322A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030032484A (ko) * 2001-10-18 2003-04-26 롯데제과주식회사 발암 억제효능을 갖는 데오브로민
JP2004018512A (ja) * 2002-06-20 2004-01-22 Morinaga & Co Ltd 冷え性改善用組成物および冷え性改善用組成物の製造のためのカカオ豆加工物の使用
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (ko) * 2006-07-25 2008-01-30 안국약품 주식회사 기침 치료용 조성물
US7914828B2 (en) * 2008-10-17 2011-03-29 Levine Brian M Combination herbal product to benefit respiratory tract
GB0919893D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
GB0921803D0 (en) 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
GB0919889D0 (en) 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
US20150216869A1 (en) * 2009-06-16 2015-08-06 Biocopea Limited Drug Combinations and Uses in Treating a Coughing Condition
US20150005325A1 (en) * 2009-06-16 2015-01-01 Biocopea Limited Drug Combinations and Uses in Treating a Coughing Condition
GB0921805D0 (en) * 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201014391D0 (en) 2010-08-27 2010-10-13 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
AU2015201845B2 (en) * 2009-11-13 2015-11-05 Infirst Healthcare Limited Drug combination with theobromine and its use in therapy
US8361519B2 (en) 2010-11-18 2013-01-29 Aadvantics Pharmaceuticals, Inc. Combination herbal product to benefit respiratory tract in people exposed to smoke
NL1040474C2 (en) 2013-10-31 2015-05-04 Veramed B V Nasal compositions stimulating ciliary activity.
ES2552706B1 (es) * 2014-05-29 2016-09-13 Universitat De Les Illes Balears La teobromina y sus derivados para el tratamiento o prevenciónde la litiasis renal
KR20160126217A (ko) 2015-04-23 2016-11-02 주식회사 진명 에프 엠 씨 용기 투입장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1113122B (it) * 1978-04-06 1986-01-20 Abc Ist Biolog Chem Spa Composizione farmaceutica ad attivita' antibrocospastica e antitosse
FR2531339A1 (fr) * 1982-08-04 1984-02-10 Dietlin Francois Nouveau procede d'obtention de formes pharmaceutiques a liberation programmee
HU197574B (en) * 1986-10-09 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for production of derivatives of 3,7-dihydro-3-methil-7-//1,2,4-oxadiasole/-3-il/alkylenil/-1h-purin-2,6-dion and medical compositions containing these substances
GB2201591B (en) * 1987-03-02 1990-11-14 Ricerfarma Srl Analgesic antipyretic and anti-inflammatory compositions.
US5009819A (en) * 1987-11-12 1991-04-23 The Liposome Company, Inc. Taste moderating composition
DK339289D0 (da) 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
WO1995007103A1 (en) 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
US5560913A (en) 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5641512A (en) 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
AU6599196A (en) * 1995-07-28 1997-02-26 Procter & Gamble Company, The Compositions containing analgesics and antihistamines and methods for treating respiratory disorders

Also Published As

Publication number Publication date
BR9809057A (pt) 2000-08-01
EP0969843B1 (en) 2002-06-12
JP2001518928A (ja) 2001-10-16
DE69805983D1 (de) 2002-07-18
WO1998042322A2 (en) 1998-10-01
HUP9700654A2 (hu) 1999-09-28
EA001971B1 (ru) 2001-10-22
SK285023B6 (sk) 2006-04-06
AU6741498A (en) 1998-10-20
EE9900428A (et) 2000-04-17
WO1998042322A3 (en) 1998-12-17
EP0969843A2 (en) 2000-01-12
JP4450872B2 (ja) 2010-04-14
CZ339199A3 (cs) 2000-04-12
DK0969843T3 (da) 2002-10-07
PL190899B1 (pl) 2006-02-28
US6348470B1 (en) 2002-02-19
EA199900876A1 (ru) 2000-04-24
IL131811A (en) 2006-06-11
CA2284774A1 (en) 1998-10-01
BG103780A (en) 2001-04-30
CN1251039A (zh) 2000-04-19
KR20010005642A (ko) 2001-01-15
ATE218868T1 (de) 2002-06-15
PT969843E (pt) 2002-10-31
CA2284774C (en) 2005-12-06
HU9700654D0 (en) 1997-05-28
NO994640D0 (no) 1999-09-24
DE69805983T2 (de) 2003-01-30
IL131811A0 (en) 2001-03-19
KR100420370B1 (ko) 2004-03-03
SK127399A3 (en) 2000-09-12
CZ295801B6 (cs) 2005-11-16
PL335979A1 (en) 2000-06-05
ES2178188T3 (es) 2002-12-16

Similar Documents

Publication Publication Date Title
CA2283280A1 (en) Reovirus for the treatment of neoplasia
TW262461B (no)
AU2147992A (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
NO994640D0 (no) Hostestillende midler
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
NO873589L (no) Blanding som inneholder ldopa.
NO974693L (no) Farmasöytisk preparat inneholdende N-klorfenylkarbamater, N-klorfenyltiokarbamater og N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus i pattedyr
NO164904C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive griseolsyrederivater.
AU2861389A (en) Disubstituted pyridines
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
SE8403659L (sv) Synergistiska farmaceutiska kompositioner
IE870577L (en) Topical amide preparation
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
AU6942896A (en) Use of muteins of wild-type cytokines as immunogens
NO990283L (no) Formulering for behandling og/eller profylakse av demens
ES8505968A1 (es) Procedimiento para preparar (6-(etil-(2-hidroxipropil)-amino)-3-piridazinil)-hidrazinocarboxilato de etilo
KR910002455A (ko) 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
ATE74505T1 (de) Schmerzpraeparat.
JPS5699420A (en) Immune reactivator
SE7703625L (sv) Forfarande for beredning av ensilage
CO4750838A1 (es) Metodo para el tratamiento de reacciones inflamatorias adversas y la composicion antiinflamatoria administrada
UA38590A (uk) Спосіб лікування гломерулонефриту з анефротичним синдромом та гематуричним компонентом

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application